RARE
Price
$36.06
Change
-$0.08 (-0.22%)
Updated
Jun 3, 10:52 AM (EDT)
Capitalization
3.42B
58 days until earnings call
RNA
Price
$33.21
Change
+$0.04 (+0.12%)
Updated
Jun 3, 10:37 AM (EDT)
Capitalization
4B
70 days until earnings call
Interact to see
Advertisement

RARE vs RNA

Header iconRARE vs RNA Comparison
Open Charts RARE vs RNABanner chart's image
Ultragenyx Pharmaceutical
Price$36.06
Change-$0.08 (-0.22%)
Volume$100
Capitalization3.42B
Avidity Biosciences
Price$33.21
Change+$0.04 (+0.12%)
Volume$100
Capitalization4B
RARE vs RNA Comparison Chart
Loading...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RARE vs. RNA commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RARE is a Hold and RNA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (RARE: $36.14 vs. RNA: $33.17)
Brand notoriety: RARE and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RARE: 106% vs. RNA: 87%
Market capitalization -- RARE: $3.42B vs. RNA: $4B
RARE [@Biotechnology] is valued at $3.42B. RNA’s [@Biotechnology] market capitalization is $4B. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RARE’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • RARE’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RARE’s TA Score shows that 6 TA indicator(s) are bullish while RNA’s TA Score has 6 bullish TA indicator(s).

  • RARE’s TA Score: 6 bullish, 3 bearish.
  • RNA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both RARE and RNA are a good buy in the short-term.

Price Growth

RARE (@Biotechnology) experienced а +1.35% price change this week, while RNA (@Biotechnology) price change was +8.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.53%. For the same industry, the average monthly price growth was +5.67%, and the average quarterly price growth was +2.90%.

Reported Earning Dates

RARE is expected to report earnings on Jul 31, 2025.

RNA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($4B) has a higher market cap than RARE($3.42B). RNA YTD gains are higher at: 14.065 vs. RARE (-14.096). RNA (-430.35M) and RARE (-449.9M) have comparable annual earnings (EBITDA) . RNA has more cash in the bank: 1.38B vs. RARE (494M). RNA has less debt than RARE: RNA (5.97M) vs RARE (38.3M). RARE has higher revenues than RNA: RARE (591M) vs RNA (8.93M).
RARERNARARE / RNA
Capitalization3.42B4B85%
EBITDA-449.9M-430.35M105%
Gain YTD-14.09614.065-100%
P/E RatioN/AN/A-
Revenue591M8.93M6,620%
Total Cash494M1.38B36%
Total Debt38.3M5.97M641%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RARERNA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EPU47.721.08
+2.32%
iShares MSCI Peru ETF
DOGG19.830.09
+0.45%
FT Vest DJIA® Dogs 10 Trgt Inc ETF
AUDJPY92.65N/A
N/A
Australian Dollar - Japan Yen
VKI8.28-0.02
-0.24%
Invesco Advantage Municipal Income Trust II
ICLN12.59-0.08
-0.63%
iShares Global Clean Energy ETF